Skip to main content
Clinical Trials/NCT07613372
NCT07613372Active, not recruitingNot Applicable

Evaluation of Cardiac Autonomic Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus

Marwa Abouelela Abd Elsalam1 site in 1 country75 target enrollmentStarted: February 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
75
Locations
1

Study Overview

Brief Summary

study is to evaluate the prevalence of cardiac autonomic neuropathy in children with Type 1 DM and correlation with duration of DM and glycemic control.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
6 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≤18 years old Both males and females will be included. Patients diagnosed with type 1 DM for a duration ≥ 5 y. Both well controlled and poorly controlled patients will be included.

Exclusion Criteria

  • Patients with diabetes other than Type 1 DM. Coexisting medical conditions such as thyroid disorders, celiac disease, epilepsy, or chronic pulmonary or hepatic disease.
  • Known cardiac conditions, including congenital heart disease, cardiomyopathy, conduction disorders, or previous cardiac surgery.
  • Acute illness at the time of evaluation or history of diabetic ketoacidosis within the preceding 3 months.
  • Use of medications affecting heart rate or rhythm, including beta-blockers, theophylline, or levothyroxine

Investigators

Sponsor
Marwa Abouelela Abd Elsalam
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Marwa Abouelela Abd Elsalam

Assistant lecturer of paediatrics faculty of medicine Tanta university

Tanta University

Study Sites (1)

Loading locations...

Similar Trials